| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Telmisartan | Diabetes Type 2 | 2 | PM | 37576807 | 📋 | Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model |
| Telmisartan | Diabetes Type 2 | 1 | PM | 34594226 | 📋 | Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARĪ³ |
| Telmisartan | Insulin Resistance | 1 | PM | 37576807 | 📋 | Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model |
| Telmisartan | Metabolic Syndrome | 2 | PM | 38653362 | 📋 | Telmisartan ameliorates nephropathy and restores the hippo pathway in rats with metabolic syndrome |
| Telmisartan | Metabolic Syndrome | 1 | PM | 38228033 | 📋 | Effects of telmisartan on metabolic syndrome components: a comprehensive review |
| Telmisartan | Mitochondrial Dysfunction | 1 | PM | 38419447 | 📋 | Telmisartan Protects Mitochondrial Function, Gait, and Neuronal Apoptosis by Activating the Akt/GSK3β/PGC1α Pathway in an MPTP-Induced Mouse Model of Parkinson's Disease |
| Telmisartan | Obesity | 2 | PM | 37831115 | 📋 | Telmisartan and candesartan promote browning of white adipose tissue and reverse fatty liver changes in high fat diet fed male albino rats |
| Telmisartan | Obesity | 1 | PM | 33761942 | 📋 | Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension |
